Identifying Risk Factors for Left Ventricular Thrombus in Patients with Ischemic Left Ventricular Aneurysm Using

Yanfang Wu1, Hui Wang2, Zhiyan Wang1

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Thrombosis and Haemostasis
|February 11, 2025
PubMed

Insights

Left ventricular (LV) aneurysms with wider necks, higher shape indices, and extensive late gadolinium enhancement (>50%) predict thrombus formation. These findings aid in assessing embolic risk in ischemic LV aneurysm patients.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Medical Research

Background:

  • Ischemic left ventricular (LV) aneurysm is linked to LV thrombus and embolic events.
  • Current guidelines lack evidence-based recommendations for anticoagulation in these patients.

Purpose of the Study:

  • To identify characteristics of LV aneurysms associated with a high risk of thrombus formation.
  • To inform risk stratification and potential therapeutic strategies for patients with ischemic LV aneurysm.

Main Methods:

  • Retrospective study of 317 hospitalized patients with ischemic LV aneurysm undergoing cardiac magnetic resonance (CMR).
  • Comparison of baseline characteristics and CMR parameters between patients with and without LV thrombus.
  • Logistic regression analysis to identify significant predictors of LV thrombus.

Main Results:

  • 88 (27.8%) patients had LV thrombus, associated with heart failure and reduced ejection fraction.
  • Significant predictors of LV thrombus included wider aneurysm neck width (OR 1.33), higher shape index (OR 1.63), and LGE global extent >50% (OR 6.58).
  • Patients with LV thrombus showed greater LV volume, mass, and LGE extent.

Conclusions:

  • Wider aneurysm neck, higher aneurysm shape index, and extensive LGE (>50%) are key predictors of LV thrombus in ischemic LV aneurysm.
  • These imaging markers can help identify patients at higher risk for embolic events.
  • Further research is warranted to establish anticoagulation guidelines for this patient group.